Evidence map›Paper›PMID 27035997›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

Enhanced gene targeting to evaluate Lynch syndrome alterations.

Richard Fishel, Christopher D Heinen

Abstract readEditorialComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Richard FishelDepartment of Molecular Virology, Immunology and Medical Genetics, The Ohio State University Wexner Medical Center, Columbus, OH 43210; Department of Physics, The Ohio State University, Columbus, OH 43210; rfishel@osu.edu cheinen@uchc.edu.
Christopher D HeinenCenter for Molecular Medicine, University of Connecticut Health, Farmington, CT 06030; Neag Comprehensive Cancer Center, University of Connecticut Health, Farmington, CT 06030 rfishel@osu.edu cheinen@uchc.edu.

Funding

The Human Mismatch Repair Proteins and CarcinogenesisR01CA067007 · NCI · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI Richard Fishel · 1995 to 2026
$9.6M
NCI NIH HHS R01 CA067007
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Colorectal Neoplasms, Hereditary NonpolyposisGene TargetingGerm-Line MutationHumansMutS Homolog 2 ProteinMutS Homolog 2 Protein

Identifiers

PMID27035997
PMCPMC4839465

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.